Asian longhorned beetle bioassays to evaluate formulation and dose-response effects of Metarhizium microsclerotia

Eric H Clifton1, Sana Gardescu1, Robert W Behle2

  • 1Department of Entomology, Cornell University, Ithaca, NY, USA.

Insights

Metarhizium brunneum fungus effectively controls invasive Asian longhorned beetles (ALB). Formulated microsclerotia achieved 100% adult ALB mortality in field trials, demonstrating a promising biocontrol strategy.

Area of Science:

  • Entomology
  • Biological Control
  • Forestry

Background:

  • Asian longhorned beetles (Anoplophora glabripennis) are destructive invasive wood-boring insects.
  • Metarhizium brunneum is a fungal pathogen known to infect and kill various insects, including ALB.
  • Dried microsclerotia of M. brunneum can be formulated for delayed release of infective conidia.

Purpose of the Study:

  • To evaluate the efficacy of formulated Metarhizium brunneum microsclerotia as a biocontrol agent against Asian longhorned beetles.
  • To assess the impact of a humectant hydrogel on the efficacy of the fungal formulation.
  • To determine the dose-response relationship between fungal application rate and ALB mortality.

Main Methods:

  • Wood samples treated with M. brunneum microsclerotia were deployed in the Ohio ALB-eradication zone.
  • Adult ALB were exposed to treated wood samples under field conditions.
  • Mortality rates were recorded, and formulation components (humectant hydrogel) and application rates were varied.

Main Results:

  • Formulated microsclerotia applied to wood samples resulted in 100% mortality of exposed adult ALB within four weeks.
  • The inclusion of humectant hydrogel in the formulation did not significantly enhance ALB mortality.
  • A clear dose-response relationship was observed, with higher application rates and conidial densities leading to decreased ALB survival.

Conclusions:

  • Metarhizium brunneum, formulated as dried microsclerotia, is a highly effective agent for controlling adult Asian longhorned beetles.
  • The tested formulation shows significant potential for use in ALB eradication programs.
  • Further research into optimizing application rates and formulation stability is warranted.

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
720
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.6K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
289
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
232